Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1145482

Cover Image

PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1145482

Insulin Pump Market: Current Analysis and Forecast (2022-2028)

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3999
PDF (Site License)
USD 5499
PDF (Global License)
USD 6999

Add to Cart

The global Insulin Pump Market is expected to grow at a significant rate of around 9% during the forecast period. Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin pumps are used for external insulin delivery, providing a convenient option for diabetes treatment. Insulin pumps are observing a significant growth in demand in recent years, owing to an increase in the number of diabetic patients, rising obesity, and a sedentary lifestyle. Furthermore, advancements in human insulin delivery systems, innovations in insulin delivery system techniques, and healthy reimbursement policies, as well as rising awareness among the population about diabetes control and accessibility to insulin delivery systems, are all factors ensuring the market's growth. For instance, as per CDC, from 1999 -2000 through 2017 -March 2020, US obesity prevalence increased from 30.5% to 41.9%. During the same time, the prevalence of severe obesity increased from 4.7% to 9.2%.

Medtronic, F. Hoffmann-La Roche Ltd, Tandem Diabetic Care, Inc., Insulet Corporation, Ypsomed, Cellenovo, Sooil Development, Valeritas Inc., JingasuDelfu Co. Ltd., Diabeloop SACA. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product type, pumps category to witness robust CAGR during the forecast period"

Based on product type, the market is segmented into pumps and consumables. pumps category to witness the fastest growth during the forecast period owing to the rising obesity, awareness towards health, and increasing smoking are the major factors for the growth of this segment. As per Elizabeth Gasser, Pair's central methodology official, the overall pump reception among patients with type 1 diabetes increments with the entrance in the U.S. also, global business sectors, hitting around 65% and 20% by 2027, individually.

"Amongst disease indication, the type 1 diabetes to hold a significant share in the market in 2020"

On the basis of disease indication, the market is categorized into type 1 diabetes and type 2 diabetes. Among these, type 1 diabetes to hold a significant growth during the forecast period. This is mainly due to the increasing prevalence of type 1 diabetes worldwide. For example, as per the International Diabetes Federation (IDF), around 1.2 million youngsters and youths have type 1 diabetes in 2021. Since patients with type 1 diabetes are insulin-reliant, the requirement for insulin pumps and other consumables is similarly higher among these patients.

"North America to hold a significant share in the market"

For a better understanding of the market adoption of the insulin pump industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to rising obesity, technological advancement, product launches, and improvements in its healthcare sector and the implementation of advanced medical products are augmenting the demand for insulin pumps in the region that are expected to drive the market in the region. For instance, according to the United Nations, the 60+ aged population was 962 million in 2017 which is more than twice that it was in 1980 at 382 million. The elderly population is expected to double again by 2050 and reach nearly 2.1 billion worldwide. For instance, as per CDC, 1.6 million adults aged 20 years or older, or 5.7% of all US adults have been diagnosed with diabetes.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.

Customization Options:

The global insulin pump market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Product Code: UMHE211216

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Insulin Pump Market
  • 2.2. Research Methodology of the Insulin Pump Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE INSULIN PUMP MARKET

6 INSULIN PUMP MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1. Pumps
  • 7.2. Consumables

8 MARKET INSIGHTS BY DISEASE INDICATION

  • 8.1. Type 1 Diabetes
  • 8.2. Type 2 Diabetes

9 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 9.1. Hospital Pharmacy
  • 9.2. Retail & Online Pharmacy

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 INSULIN PUMP MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 INSULIN PUMP MARKET OPPORTUNITIES

13 INSULIN PUMP MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Five Forces Analysis

17 COMPANY PROFILED

  • 17.1. Medtronic
  • 17.2. F. Hoffmann-La Roche Ltd
  • 17.3. Tandem Diabetic Care Inc.
  • 17.4. Insulet Corporation
  • 17.5. Ypsomed
  • 17.6. Cellenovo
  • 17.7. Sooil Development
  • 17.8. Valeritas Inc
  • 17.9. JingasuDelfu Co. Ltd.
  • 17.10. Diabeloop SACA

18 DISCLAIMER

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!